DigitalCommons@Fairfield
metadata only
Willingness to Pay for CRISPR-Based Gene Therapies: A Contingent Valuation Study
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Affordable pricing of CRISPR treatments is a pressing ethical imperative#87282
- A “Bare Hope of A Result”: The Second CRISPR Patent Appeal#333966
- Principles and practices for successful gene therapy innovative contracting: Insights from a multistakeholder convening.#335939
- Innovative Contracting for Gene Therapies: Current Landscape and Perspectives on the Future of Gene Therapy Financing in the USA.#140921
- Innovative Contracting for Gene Therapies: Current Landscape and Perspectives on the Future of Gene Therapy Financing in the USA.#138615
Record · ID 196526
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive